We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Outperforms Broader Market: What You Need to Know
Read MoreHide Full Article
In the latest close session, UnitedHealth Group (UNH - Free Report) was up +2.85% at $313.00. The stock outpaced the S&P 500's daily gain of 1.02%. At the same time, the Dow added 0.63%, and the tech-heavy Nasdaq gained 1.23%.
The stock of largest U.S. health insurer has risen by 7.88% in the past month, leading the Medical sector's loss of 4.81% and the S&P 500's gain of 0.63%.
Investors will be eagerly watching for the performance of UnitedHealth Group in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on April 21, 2026. It is anticipated that the company will report an EPS of $6.48, marking a 10% fall compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $109.9 billion, showing a 0.29% escalation compared to the year-ago quarter.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $17.66 per share and a revenue of $440.36 billion, indicating changes of +8.01% and -1.61%, respectively, from the former year.
It is also important to note the recent changes to analyst estimates for UnitedHealth Group. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.17% lower. UnitedHealth Group presently features a Zacks Rank of #3 (Hold).
Looking at valuation, UnitedHealth Group is presently trading at a Forward P/E ratio of 17.23. This valuation marks no noticeable deviation compared to its industry average Forward P/E of 17.23.
One should further note that UNH currently holds a PEG ratio of 1.4. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. Medical - HMOs stocks are, on average, holding a PEG ratio of 0.94 based on yesterday's closing prices.
The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 225, putting it in the bottom 8% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
UnitedHealth Group (UNH) Outperforms Broader Market: What You Need to Know
In the latest close session, UnitedHealth Group (UNH - Free Report) was up +2.85% at $313.00. The stock outpaced the S&P 500's daily gain of 1.02%. At the same time, the Dow added 0.63%, and the tech-heavy Nasdaq gained 1.23%.
The stock of largest U.S. health insurer has risen by 7.88% in the past month, leading the Medical sector's loss of 4.81% and the S&P 500's gain of 0.63%.
Investors will be eagerly watching for the performance of UnitedHealth Group in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on April 21, 2026. It is anticipated that the company will report an EPS of $6.48, marking a 10% fall compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $109.9 billion, showing a 0.29% escalation compared to the year-ago quarter.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $17.66 per share and a revenue of $440.36 billion, indicating changes of +8.01% and -1.61%, respectively, from the former year.
It is also important to note the recent changes to analyst estimates for UnitedHealth Group. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.17% lower. UnitedHealth Group presently features a Zacks Rank of #3 (Hold).
Looking at valuation, UnitedHealth Group is presently trading at a Forward P/E ratio of 17.23. This valuation marks no noticeable deviation compared to its industry average Forward P/E of 17.23.
One should further note that UNH currently holds a PEG ratio of 1.4. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. Medical - HMOs stocks are, on average, holding a PEG ratio of 0.94 based on yesterday's closing prices.
The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 225, putting it in the bottom 8% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.